Compounds > imidazolium-bis(imidazole)tetrachlororuthenate(iii)
Page last updated: 2024-09-03

imidazolium-bis(imidazole)tetrachlororuthenate(iii) and Lung Neoplasms

imidazolium-bis(imidazole)tetrachlororuthenate(iii) has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessio, E; Bregant, F; Ceschia, V; Mestroni, G; Pacor, S; Sava, G1

Other Studies

1 other study(ies) available for imidazolium-bis(imidazole)tetrachlororuthenate(iii) and Lung Neoplasms

ArticleYear
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
    Chemico-biological interactions, 1991, Volume: 78, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma; Cisplatin; Imidazoles; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Organometallic Compounds; Ruthenium; Survival Analysis

1991